| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/06/2005 | WO2005040119A1 Tetrahydro-naphthalene and urea derivatives |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | WO2005040095A1 Inhibitors of dipeptidyl peptidase iv |
| 05/06/2005 | WO2005027157A3 Salt fusible at ordinary temperature and electrochemical device |
| 05/06/2005 | WO2005019240A3 Melanin concentrating hormone receptor antagonists |
| 05/06/2005 | WO2005012249A3 Adamantyglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | WO2004002939A3 Aminoalcohol derivatives |
| 05/06/2005 | CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096385 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096330 N-(indolecarbonyl) piperazine derivatives |
| 05/05/2005 | US20050096326 4-(4-methylpiperazin-1-yl)4V-(4-morpholinophenyl)-indan-2-carboxamide; h5-HT1B receptor antagonist; serotonin-mediated disorders; oral bioavailability |
| 05/05/2005 | US20050091763 Hair cosmetic, aminocarboxylic acid amide and method for producing the same |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | EP1246790B1 Substituted 1 and 2 naphthol mannich bases |
| 05/04/2005 | EP0958280B1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 05/04/2005 | EP0755923B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor |
| 05/03/2005 | US6888029 Arylation complex catalyst |
| 05/03/2005 | US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/03/2005 | US6887878 KMST isoeugenol derivatives and pharmaceutical activity |
| 05/03/2005 | US6887876 Benzamidine derivatives |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | US6887863 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors |
| 05/03/2005 | CA2198937C Process for producing n-butyraldehyde and/or n-butanol |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 04/28/2005 | WO2005037810A2 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 04/28/2005 | WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037808A1 Phenylpiperazine cycloalkanol derivatives and methods of their use |
| 04/28/2005 | WO2005037807A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | WO2005037806A1 High-purity piperazine pyrophosphate and method for producing same |
| 04/28/2005 | WO2005037772A2 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/28/2005 | WO2005037769A1 Method for the distillative separation of mixtures containing ethyleneamines |
| 04/28/2005 | WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | WO2005037269A1 Novel piperidine derivative |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005014515A3 Clear photopolymerizable systems for the preparation of high thickness coatings |
| 04/28/2005 | WO2005004796A3 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 04/28/2005 | WO2004110978A3 1-aminonaphthalenes as modulators of androgen, glucocorticoid, mineralocorticoid and progesterone receptors |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 04/28/2005 | US20050090546 Compounds such as N,N-dibenzylphenylalanine benzyl ester, used as enzyme inhibitors; prophylaxis of lymphadenopathy associated virus, cancer and malaria |
| 04/28/2005 | US20050090514 Cool-genic compounds as anticarcinogenic agents promoting apoptosis and inhibit angiogenesis; antiproliferative agents |
| 04/28/2005 | US20050090478 Platinum complexes and their use in cancer treatment |
| 04/28/2005 | US20050090381 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 04/28/2005 | CA2549733A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 04/28/2005 | CA2540207A1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2540191A1 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 04/28/2005 | CA2539763A1 Phenylpiperazine cycloalkanol derivatives and methods of their use |
| 04/28/2005 | CA2539761A1 Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/28/2005 | CA2539059A1 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/27/2005 | EP1525195A2 Method for the production of phenylalanine derivatives |
| 04/27/2005 | EP1525194A1 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 04/27/2005 | EP1525186A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1525183A1 Inhibitors of hcv ns5b polymerase |
| 04/27/2005 | EP1025097B1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d 4? receptor subtype ligands |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610668A Substituted propane-1, 3-diamine derivatives and the pharmaceutical use |
| 04/27/2005 | CN1610660A Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1198617C Remedies for cardiac dilastolit disorders |
| 04/26/2005 | US6884887 Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds |
| 04/26/2005 | US6884803 Phenylalkynes |
| 04/26/2005 | CA2244134C Diphenyl stilbenes as prodrugs to cox-2 inhibitors |
| 04/26/2005 | CA2194203C Process for the preparation of o-chloromethyl-phenylglyoxylic acid derivatives |
| 04/21/2005 | WO2005034940A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 04/21/2005 | WO2005034878A2 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | WO2005034848A2 Inhibitors of cathepsin s |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085655 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 04/21/2005 | US20050085555 Composition, synthesis and therapeutic applications of polyamines |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/21/2005 | US20050085507 p-phenylethenyl hydroxamates; anticarcinogenic, antitumor, antiproliferative agents; regulating p21 promoter; improved stability |
| 04/21/2005 | US20050085474 difluoroamine compounds |
| 04/21/2005 | CA2542077A1 Pyrovalerone analogs and therapeutic uses thereof |
| 04/21/2005 | CA2535930A1 Inhibitors of cathepsin s |
| 04/20/2005 | EP1524262A1 Inhibitors of histone deacetylase |
| 04/20/2005 | EP1523471A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1210330B1 Antibacterial agents |
| 04/20/2005 | EP1165495B1 Resorcinol derivatives |
| 04/20/2005 | EP1029851B1 Piperazine compounds and medicinal use thereof |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/20/2005 | CN1607935A Primary intermediates for oxidative coloration of hair |
| 04/19/2005 | US6881841 Dibenzosuberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881738 Analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/14/2005 | WO2005033088A1 Quinoxaline compounds |
| 04/14/2005 | WO2005033063A2 Melanin concentrating hormone antagonists |